Foreign Investors’ Rights under New Pharma Decree – Are we there yet?

19 May, 2017

Start adding items to your reading lists:
Save this item to:
This item has been saved to your reading list.

Vietnam’s New Pharma Decree opens the door for foreign-invested pharmaceutical companies to actually exercise their long-time awaited import rights.  This note sets out the key changes.

Get in touch

Richard J. Irwin
Chairman/Partner, Tax Services, PwC Vietnam
Tel: +84 28 3824 0117

Nasir Dao - PKM Abdul
Partner, Legal Services, PwC Vietnam
Tel: +84 28 3824 0109

Follow us